1-2 of 2
William Petros
Close
Sort by
Journal Articles

Serum Mir-29a Is Up-Regulated In Acute Graft Versus Host Disease (aGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) and Activates Dendritic Cells (DCs)

Yvonne A Efebera, MD, Parvathi Ranganathan, Ph.D, Xueyan Yu, Ph.D, Jessica Hofstetter, BS, Sabrina L Garman, BS, Laura Gibson, PhD, William Petros, Michael Craig, MD, Cecelia Fernandez-Cymering, BS, Mehdi Hamadani, MD, Guido Marcucci, MD, Steven M. Devine, MD, Muller Fabbri, MD, Ramiro Garzon, MD
Journal: Blood
Blood (2013) 122 (21): 4471.
https://doi.org/10.1182/blood.V122.21.4471.4471
Published: 2013
Journal Articles

Immunomodulation of Both Donors and Recipients with Atorvastatin As a Strategy for the Prevention of Acute Graft-Versus-Host Disease (aGVHD): Results of Two Parallel Prospective Trials in Recipients of Matched Sibling Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Mehdi Hamadani, MD, Michael Craig, MD, Scot Remick, MD, FACP, Laura Gibson, PhD, William Petros, Jame Abraham, MD, FACP, Aaron Cumpston, PharmD, Pamela Bunner, BS, Soumit Basu, MD, William Tse, MD, Carrie Hennelly, Sumithira Vasu, MBBS, Rebecca B Klisovic, MD, William Blum, MD, Samantha M. Jaglowski, MD, MPH, Don M. Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Sam Penza, MD, Craig C. Hofmeister, MD, Susan Geyer, PhD, Steven M. Devine, MD, Yvonne A Efebera, M.D.
Journal: Blood
Blood (2012) 120 (21): 1942.
https://doi.org/10.1182/blood.V120.21.1942.1942
Published: 2012